The Wien Center for Alzheimer's Disease and Memory Disorders,
Mount Sinai Medical Center, Miami Beach presents:

12th Mild Cognitive Impairment Symposium

3rd Early Alzheimer's Diagnostic and Treatment Workshop

2nd Alzheimer's Public Educational Forum

January 18-19, 2014 Miami, Florida, USA

 

Live recording
of 2014 EVENT

read more

Live recording
of 2013 EVENT

read more

HAI 2014

As in 2013, this event will be held back to back with the 8th Human Amyloid Imaging (HAI) Conference. This event will be presented at the same venue between January 15-17, 2014.

ABOUT THIS EVENT

The Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach will present the:

  • 12th Mild Cognitive Impairment (MCI) Symposium
  • 3rd Early Alzheimer's Diagnostic and Treatment Workshop, and
  • 2nd Mount Sinai of Florida's Early Alzheimer's Public Educational Forum
in Miami Beach, Florida, USA.

HISTORY

The MCI Symposium series was initiated in 2003 by the Wien Center for Alzheimer's Disease and Memory Disorders, at Mount Sinai Medical Center, Miami Beach, under the direction of Ranjan Duara, MD. The purpose of the first and subsequent symposia have been to provide a forum where new information is provided and in-depth discussions can take place about the earliest stages of Alzheimer's disease and other conditions that result in cognitive impairment in the elderly. The symposia have featured national and international experts in the fields of neurology, neuropsychology, psychiatry, geriatrics, epidemiology, genetics, imaging and neuropathology. The topics discussed at these symposia have included the biology, early detection, prevention and treatment of conditions that result in cognitive impairment in the elderly.

TARGET AUDIENCE

The MCI Symposium and the Early Alzheimer's Diagnostic and Treatment Workshop will attract: Neurologists, Psychiatrists, Geriatricians, Gerontologists, Epidemiologists, Neuropsychologists, Psychologists, Neuroscientists.

The 2nd Alzheimer's Public Educational Forum will attract individuals with Alzheimer's disease, at-risk family members and caregivers.

THEMES

MCI Symposium:

The symposium's theme will be centered on the influence of amyloid deposition, neurodegeneration and other risk factors on cognitive and functional changes across the MCI spectrum. In particular, the symposium will focus on (a) Correlates of Brain Aβ Deposition and Neurodegeneration in Normal and Abnormal Aging, and (b) Approaches to Measuring Cognitive and Functional Change Across the MCI Spectrum.

Early Alzheimer's Disease Workshop:

The workshop will present "Diagnostic Case Studies of Preclinical AD, MCI-AD and Probable AD". Cases with concordant and discordant biomarkers and clinical results will be discussed. Several cases with follow-up to autopsy will be included.

Early Alzheimer Public Education Forum:

The Early Alzheimer's Public Educational Forum is intended for at-risk family members, caregivers, the public at large and professionals. This educational segment will focus on "The role of Amyloid Imaging in the Diagnosis of Mild Cognitive Impairment" and will aim to provide information about the latest research in the field. The forum will allow the audience to interact with top scientists in the field in the presence of a moderator.

PREVIOUS AGENDAS